PlainRecalls
FDA Drug Moderate Class II Ongoing

Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.

Reported: July 24, 2024 Initiated: June 28, 2024 #D-0601-2024

Product Description

Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.

Reason for Recall

Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.

Details

Units Affected
116,144 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.. Recalled by Teva Pharmaceuticals USA, Inc. Units affected: 116,144 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 24, 2024. Severity: Moderate. Recall number: D-0601-2024.